Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Halozyme Therapeutics, Inc.

NASDAQ: HALO · Life Sciences · 10 alerts · CIK 1159036

Share price
$96.50Close, Nov 16
Market cap
$11B
Shares outstanding
114.01MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Halozyme Therapeutics, Inc. filings on SEC EDGAR ↗

4:16 PM ET 10-Q
Financial Results

Halozyme Therapeutics Q3 2026 Results: Net Income $247M, Up 41.0% YoY

Halozyme Therapeutics reported strong growth for the third quarter of 2026, with total revenues increasing to $493.0 million compared to $354.3 million in the prior year, driven primarily by higher royalty and product sales. Net income rose to $247.0 million, while the company significantly restructured its debt through the issuance of 2033 Convertible Notes and the repayment of 2027 and 2028 notes.

Key figure
Net income $247M · +41.0% YoY
4:13 PM ET 8-K
Financial Results

Halozyme Therapeutics Financial Results

Halozyme Therapeutics reported record Q3 2026 financial results with total revenue increasing 39% year-over-year to $493 million, driven by a 44% surge in royalty revenue. Based on strong performance, the company raised its full-year 2026 guidance for revenue, adjusted EBITDA, and non-GAAP EPS while highlighting a legal victory in the Netherlands protecting its intellectual property against Merck.

Term
Q3 2026

“Halozyme delivered another exceptional quarter, with total revenue increasing 39% and royalty revenue growing 44% year-over-year to record levels.”

Dr. Helen Torley, President and Chief Executive Officer

“Based on our strong financial performance this quarter, we are pleased to be able to raise our guidance for the full year 2026.”

Darren Snellgrove, Executive Vice President and Chief Financial Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.